Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Acta Medica Austriaca|January 1, 1983
[Emission-computed tomography of the myocardium with the 7-pinhole collimator]H Sochor, O Pachinger, E Ogris, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1978
Assessment of regional wall motion in coronary artery disease using radionuclide methodsE Ogris, O Pachinger, H Sochor, et al.Chest|December 1, 1982
Myocardial perfusion evaluated by contrast echocardiography. A preliminary reportM Klicpera, D Glogar, H Mayr, et al.Pacing and Clinical Electrophysiology : PACE|November 1, 1984
Reversible end-of-life indicator leading to erroneous pacemaker replacement-pitfalls of telemetryW Scheibelhofer, J Kaliman, H Mayr, et al.Pacing and Clinical Electrophysiology : PACE|July 1, 1983
Reversible EOL-indicator: a new cause for low pacemaker rateW Scheibelhofer, J Kaliman, A Laczkovics, et al.British Heart Journal|August 1, 1979
Assessment of left ventricular performance and myocardial viability using quantitative radioisotope techniquesO Pachinger, E Ogris, P Probst, et al.Zeitschrift Fur Kardiologie|January 1, 1993
The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activatorK Huber, R Beckmann, F Rauscha, et al.Thrombosis Research|September 15, 1989
Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatmentK Huber, I Resch, D Rosc, et al.Acta Medica Austriaca|January 1, 1984
[Ergometry and long-term ECG for assessing bradycardiac and tachycardiac heart rhythm disorders in symptomatic patients over 70]D H Glogar, F Rauscha, L Amsüss, et al.Thrombosis and Haemostasis|January 11, 1993
Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rateK Huber, R Beckmann, P Probst, et al.Pageof 6